HIV/AIDS Clinical Trial
— iSTAMPOfficial title:
Engaging African American and Hispanic/Latino MSM for HIV Testing and Prevention Services Through Technology
Verified date | January 2024 |
Source | Emory University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will use online materials and strategies to recruit 3600 Black and Hispanic men who have sex with men (MSM) and transgender women (TGW) to participate in a study evaluating the effectiveness of the Know@Home mobile app compared to control condition with respect to linkage of participants to appropriate services, as well as cost-effectiveness outcomes.
Status | Completed |
Enrollment | 2195 |
Est. completion date | January 15, 2022 |
Est. primary completion date | September 1, 2021 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria for MSM Participants: - Black/African-American race or Hispanic/Latino ethnicity - Male sex at birth - Currently identify as male - Reported anal sex with at least one man in the past 12 months - Aged 18 or over - Has an Android or Apple mobile phone with currently active service - Currently resides in a study state: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Florida, Louisiana, California, Nevada, Texas, New York - Willing to download a study participation management mobile app - Willing to provide valid contact information so that study HIV testing kits and other materials (condoms, lubricants, STI testing kits) can be mailed to participants. - Successful completion of baseline survey Exclusion Criteria for MSM Participants: - Currently participating in another HIV prevention research study or program - Has a bleeding disorder preventing use of dried blood spot testing - Has previously participated in an HIV vaccine study. - Currently taking PrEP for HIV prevention - Self-reports living with HIV - Has plans to move out of a study state during the study period (4 months) Inclusion Criteria for TGW: - Male sex at birth - Currently identify as transgender woman or female - Aged 18 or over - Has an Android or Apple mobile smartphone with currently active service - Currently resides in a study state: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Florida, Louisiana, California, Nevada, Texas, New York - Willing to provide valid contact information so that study HIV testing kits and other materials (condoms, lubricants, STI testing kits) can be mailed to participants - Successful completion of baseline survey Exclusion Criteria for TGW: - Currently participating in another HIV prevention clinical trial or intervention - Has a bleeding disorder preventing use of dried blood spot testing - Has previously participated in an HIV vaccine study - Currently taking PrEP for HIV prevention - Self-reports living with HIV - Has plans to move out of a study state during the study period (4 months) |
Country | Name | City | State |
---|---|---|---|
United States | Emory University | Atlanta | Georgia |
Lead Sponsor | Collaborator |
---|---|
Emory University | Centers for Disease Control and Prevention |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants initiating HIV treatment | Effectiveness of the interventions will be assessed by linkage of participants to HIV treatment. | Up to Month 4 | |
Primary | Number of participants initiating PrEP treatment | Effectiveness of the interventions will be assessed by linkage of participants to PrEP treatment. | Up to Month 4 | |
Primary | Number of participants testing for STIs | Effectiveness of the interventions will be assessed by linkage of participants to STI testing. | Up to Month 4 | |
Primary | Number of participants engaging in HIV prevention services | Effectiveness of the interventions will be assessed by linkage of participants to HIV prevention services. | Up to Month 4 | |
Primary | Number of participants engaging in HIV social services | Effectiveness of the interventions will be assessed by linkage of participants to HIV social services. | Up to Month 4 | |
Primary | Cost of different online venues for study enrollment | Enrollment in the study defined as completion of the baseline survey and downloading of the study app. The cost (in US dollars) to enroll participants (online banner advertisement placement, study staff time to manage enrollment, validating participant eligibility, monitoring and evaluation of enrollment data) will be compared between the study arms. | Baseline | |
Primary | Cost of different online venues for HIV test results returned | The cost (in US dollars) of HIV tests returned within 1 month of enrollment will be compared between the study arms. The costs involved with having HIV tests returned include:
Online banner advertisement placement Study staff time managing enrollment, validating participant eligibility, monitoring and evaluation of enrollment data HIV test kits Shipping for HIV test kits Staff/personnel time to manage mailing/return of test kits Other general and administrative time, office supplies, equipment, rents, utilities |
Month 1 | |
Primary | Cost of different online venues for identifying new HIV diagnoses | The cost (in US dollars) of identifying established HIV infections will be compared between the study arms. The costs involved with identifying established HIV infections include:
Online banner advertisement placement Study staff time managing enrollment, validating participant eligibility, monitoring and evaluation of enrollment data HIV test kits Shipping for HIV test kits Staff/personnel time to manage mailing/return of test kits Study staff time to manage monitoring and evaluation of HIV test result data Study staff time to provide phone counseling to those with established infections Other general and administrative time, office supplies, equipment, rents, utilities |
Month 1 | |
Secondary | Cost of linkage to HIV counseling | The cost (in US dollars) of linking participants testing positive for HIV to HIV counseling will be compared between the study arms, including:
Study staff time spent contacting participants Study staff time for intervention maintenance (e.g., app management) HIV counseling costs to the healthcare system Other general and administrative time, office supplies, equipment, rents, utilities |
Month 4 | |
Secondary | Cost of linkage to HIV treatment | The cost (in US dollars) of linking participants testing positive for HIV to HIV treatment will be compared between the three study arms, including:
Study staff time for intervention maintenance (e.g., app management) HIV treatment costs to the healthcare system Other general and administrative time, office supplies, equipment, rents, utilities |
Month 4 | |
Secondary | Cost of linkage to PrEP counseling | The cost (in US dollars) of linking participants testing negative for HIV to PrEP counseling will be compared between the study arms, including:
Study staff time contacting participants Study staff time for intervention maintenance (e.g., app management) PrEP counseling costs to the healthcare system Other general and administrative time, office supplies, equipment, rents, utilities |
Month 4 | |
Secondary | Cost of linkage to PrEP uptake | The cost (in US dollars) of linking participants testing negative for HIV to initiate PrEP treatment will be compared between the study arms, including:
Study staff time contacting participants Study staff time for intervention maintenance (e.g., app management) PrEP uptake costs to the healthcare system Other general and administrative time, office supplies, equipment, rents, utilities |
Month 4 | |
Secondary | Cost of Sexually Transmitted Infection (STI) testing | The cost (in US dollars) of providing at-home STI testing be compared between the study arms, including:
Cost of STI testing materials and shipping Laboratory STI testing Study staff time processing orders and contacting participants Study staff time for intervention maintenance (e.g., app management) STI testing costs to the healthcare system Other general and administrative time, office supplies, equipment, rents, utilities |
Month 4 | |
Secondary | Cost of linkage to STI treatment | The cost (in US dollars) of providing treatment for STIs discovered through at-home STI testing be compared between the three study arms, including:
Study staff time processing orders and contacting participants Study staff time for intervention maintenance (e.g., app management) STI treatment costs to the healthcare system Other general and administrative time, office supplies, equipment, rents, utilities |
Month 4 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|